Oncology Institute Correlations

TOIIW Stock

USD 0.02 0 26.85%

The current 90-days correlation between The Oncology Institute and Pennant Group is -0.17 (i.e., Good diversification). The correlation of Oncology Institute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Oncology Institute Correlation With Market

Good diversification

The correlation between The Oncology Institute and DJI is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding The Oncology Institute and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy Oncology Stock please use our How to Invest in Oncology Institute guide.

Moving against Oncology Stock

0.55	ENOV	Enovis Corp	Pair Corr
0.5	GH	Guardant Health	Pair Corr
0.47	EHAB	Enhabit	Pair Corr
0.4	LH	Laboratory	Pair Corr
0.35	VVOS	Vivos Therapeutics	Pair Corr
0.31	OM	Outset Medical	Pair Corr
0.43	FOXO	FOXO Technologies	Pair Corr
0.38	SYK	Stryker	Pair Corr
0.34	COR	Cencora	Pair Corr
0.32	CAH	Cardinal Health	Pair Corr

Related Correlations Analysis

	SEM	EHC	PNTG	INNV	ACHC	SGRY	ENSG	HCSG
SEM		0.68	-0.41	-0.42	-0.44	-0.6	-0.26	0.82	SEM
EHC	0.68		-0.43	-0.48	-0.83	-0.57	-0.18	0.65	EHC
PNTG	-0.41	-0.43		0.57	0.57	0.78	0.33	-0.21	PNTG
INNV	-0.42	-0.48	0.57		0.63	0.83	0.52	-0.29	INNV
ACHC	-0.44	-0.83	0.57	0.63		0.67	0.34	-0.37	ACHC
SGRY	-0.6	-0.57	0.78	0.83	0.67		0.37	-0.49	SGRY
ENSG	-0.26	-0.18	0.33	0.52	0.34	0.37		0.04	ENSG
HCSG	0.82	0.65	-0.21	-0.29	-0.37	-0.49	0.04		HCSG
	SEM	EHC	PNTG	INNV	ACHC	SGRY	ENSG	HCSG

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SGRY	+ 0.83	INNV
HCSG	+ 0.82	SEM
SGRY	+ 0.78	PNTG
EHC	+ 0.68	SEM
SGRY	+ 0.67	ACHC
HCSG	+ 0.65	EHC

High negative correlations

ACHC	- 0.83	EHC
SGRY	- 0.6	SEM
SGRY	- 0.57	EHC
HCSG	- 0.49	SGRY
INNV	- 0.48	EHC
ACHC	- 0.44	SEM

Risk-Adjusted Indicators

There is a big difference between Oncology Stock performing well and Oncology Institute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncology Institute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SEM	1.59	(0.03)	0.02	0.11	1.84	(1.67)	3.01	(2.51)	16.75
EHC	0.91	0.13	0.05	0.49	0.83	(0.98)	1.74	(1.86)	9.75
PNTG	2.14	(0.28)	0.00	(0.07)	0.00	0.00	4.12	(3.97)	12.42
INNV	2.18	(0.55)	0.00	(0.20)	0.00	0.00	4.23	(4.81)	11.60
ACHC	2.25	(1.08)	0.00	(0.82)	0.00	0.00	3.36	(5.78)	21.88
SGRY	2.11	(0.56)	0.00	(0.36)	0.00	0.00	3.72	(4.88)	17.97
ENSG	1.05	0.01	0.00	0.08	0.00	0.00	2.32	(2.11)	10.08
HCSG	1.60	0.06	0.03	0.18	2.19	(1.61)	2.86	(3.52)	11.71

Oncology Institute Corporate Management

FACHE MD	Chief Officer	Profile
Mark Esq	General Counsel	Profile
Rob Carter	Senior Finance	Profile
Laura Szitar	Chief Officer	Profile
Richard Barasch	Executive Board	Profile
Jeremy MBA	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC